These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18413507)

  • 1. Life versus death.
    Moss AJ
    Circulation; 2008 Apr; 117(15):1912-3. PubMed ID: 18413507
    [No Abstract]   [Full Text] [Related]  

  • 2. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators.
    Sweeney MO
    Circulation; 2012 Jul; 126(3):369-77. PubMed ID: 22801654
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.
    Huikuri HV
    Europace; 2009 Dec; 11(12):1574. PubMed ID: 19933771
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.
    Daccarett M; Serafimovski N; Machado C
    Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385
    [No Abstract]   [Full Text] [Related]  

  • 6. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
    Bunch TJ; Hohnloser SH; Gersh BJ
    Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy.
    Yap SC; Schaer BA; Bhagwandien RE; Kühne M; Dabiri Abkenari L; Osswald S; Szili-Torok T; Sticherling C; Theuns DA
    Heart; 2014 Aug; 100(15):1188-92. PubMed ID: 24993502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late implantation of an implantable cardioverter-defibrillator in a patient with Brugada syndrome prevented sudden arrhythmic death.
    Mok NS; Chan NY; Choi YC
    Int J Cardiol; 2003 Feb; 87(2-3):269-71. PubMed ID: 12559549
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 12. The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.
    Green MS; Ricci J; Wolfe K
    Can J Cardiol; 2000 Jun; 16 Suppl C():13C-5C. PubMed ID: 10887271
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?
    Nishimura RA; Ommen SR
    JAMA; 2007 Jul; 298(4):452-4. PubMed ID: 17652299
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary and secondary prevention of sudden cardiac death].
    Janion M; Sadowski M; Sielski J; Janion-Sadowska A
    Pol Arch Med Wewn; 2006 Jan; 115(1):65-72. PubMed ID: 17278788
    [No Abstract]   [Full Text] [Related]  

  • 15. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.
    Ye S; Grunnert M; Thune JJ; Stephenson KM; Uno H; Finn PV; McMurray JJ; Velazquez EJ; Califf R; Pfeffer MA; Solomon SD
    Circulation; 2011 Jun; 123(23):2674-80. PubMed ID: 21606398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry.
    Page RL; Zipes DP; Powell JL; Luceri RM; Gold MR; Peters R; Russo AM; Bigger JT; Sung RJ; McBurnie MA;
    Heart Rhythm; 2004 Oct; 1(4):435-40. PubMed ID: 15851196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of sudden cardiac death].
    Klein HU
    Internist (Berl); 2006 Oct; 47(10):1040, 1042-9. PubMed ID: 16988803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chapter 1. Summary of the CCS Consensus Conference on prevention of sudden death from cardiac arrhythmia.
    Connolly SJ; Talajic M
    Can J Cardiol; 2000 Oct; 16(10):1298-302. PubMed ID: 11064304
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risk stratification for sudden cardiac death].
    Bonnemeier H; Potratz J
    Herzschrittmacherther Elektrophysiol; 2015 Mar; 26(1):3-4. PubMed ID: 25691345
    [No Abstract]   [Full Text] [Related]  

  • 20. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.